What does supraventricular tachycardia (SVT) with a heart rate (HR) of 257 beats per minute (bpm) from 0:20 to 0:40 minutes of recovery indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: May 10, 2025 • View editorial policy

From the Guidelines

These results indicate that during a cardiac stress test, the patient experienced Supraventricular Tachycardia (SVT) with a heart rate of 257 beats per minute (bpm) from 20 to 40 seconds into the recovery phase, which is a significant finding that requires prompt medical attention. The patient should be evaluated by a cardiologist as soon as possible, as this rapid heart rhythm originating from above the ventricles can cause symptoms like palpitations, dizziness, shortness of breath, or even fainting.

Key Considerations

  • Treatment options may include vagal maneuvers, medications like adenosine, beta-blockers, or calcium channel blockers to terminate the episode and prevent recurrence, as recommended by the European Heart Rhythm Association 1.
  • In some cases, catheter ablation might be recommended for long-term management.
  • SVT during recovery phase is particularly concerning as it occurs when the heart should be returning to its normal rhythm after exertion.
  • This abnormal finding may indicate underlying cardiac issues such as accessory pathways, AV nodal reentry, or atrial tachycardia that need further investigation with tests like an electrophysiology study, as outlined in the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia 2.

Clinical Implications

  • The extremely high heart rate of 257 bpm is concerning as sustained rates this high can potentially lead to hemodynamic compromise if left untreated, highlighting the need for prompt evaluation and treatment.
  • The patient's symptoms and medical history should be carefully evaluated to determine the underlying cause of the SVT and to guide treatment decisions, as suggested by the ESC guidelines for the management of patients with supraventricular tachycardia 3.
  • The patient should be monitored closely for any signs of hemodynamic instability or other complications, and treated accordingly.

From the FDA Drug Label

When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver) should be attempted prior to verapamil hydrochloride administration. In controlled studies in the United States, about 60% of patients with supraventricular tachycardia converted to normal sinus rhythm within 10 minutes after intravenous verapamil hydrochloride.

The results SVT at HR 257 bpm from 0:20 to 0:40 of recovery indicate that the patient experienced a period of supraventricular tachycardia (SVT) with a heart rate of 257 bpm during the recovery phase, specifically from 0:20 to 0:40 minutes.

  • This suggests that the patient's heart was beating very rapidly, which may be a cause for concern.
  • The use of verapamil hydrochloride may be considered to help convert the patient's heart rhythm back to normal sinus rhythm, as it is indicated for the rapid conversion of paroxysmal supraventricular tachycardias 4.

From the Research

SVT Results Explanation

The results "SVT at HR 257 bpm from 0:20 to 0:40 of recovery" indicate that the individual experienced supraventricular tachycardia (SVT) with a heart rate of 257 beats per minute (bpm) during the recovery period, specifically from 20 seconds to 40 seconds after the initial event.

Key Points to Consider

  • SVT is a condition characterized by rapid rhythms that originate and are sustained in atrial or atrioventricular node tissue above the bundle of His 5, 6.
  • The symptoms of SVT can include palpitations, light-headedness, chest discomfort, anxiety, dyspnea, or fatigue 5.
  • The diagnosis of SVT is typically made using electrocardiography (ECG) and Holter monitoring 5, 6.
  • Treatment options for SVT include vagal maneuvers, adenosine, calcium channel blockers, beta blockers, and catheter ablation 5, 6, 7, 8, 9.

Possible Causes and Treatments

  • The exact cause of SVT in this individual is not specified, but it may be related to reentry phenomena or automaticity at or above the atrioventricular node 5.
  • Treatment options may include medications such as adenosine, calcium channel blockers, or beta blockers to slow the heart rate and convert it back to a normal rhythm 5, 6, 7, 8, 9.
  • In some cases, catheter ablation may be necessary to treat SVT, especially if it is recurrent or severe 5, 6.

References

Research

Supraventricular tachycardia: An overview of diagnosis and management.

Clinical medicine (London, England), 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.